Literature DB >> 15179907

Public attitudes toward the use of psychiatric medications for children.

Jane D McLeod1, Bernice A Pescosolido, David T Takeuchi, Terry Falkenberg White.   

Abstract

Psychiatric medication use for children has increased dramatically over the past three decades. Despite substantial media attention to the issue, little is known about how the lay public feels about the use of psychiatric medications for children. Drawing on theories of medicalization, we describe and analyze Americans' attitudes towards the use of psychiatric medications generally and Prozac specifically for children described as having three types of behavioral problems. Using data from the 1998 General Social Survey's Pressing Issues in Health and Medical Care Module, we find that more Americans (57%) are willing to use psychiatric medications for children who have expressed suicidal statements than for "oppositional" behaviors (34.2%) or for hyperactivity (29.5%). Across the board, respondents are less willing to give Prozac than the general class of psychiatric medications. While socio-demographics do little to identify Americans with differing positions, the strongest and most consistent correlates of willingness to give psychiatric medications to children are trust in personal physicians, general attitudes towards psychiatric medications, and the respondent's expressed willingness to take psychiatric medications herself or himself.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15179907     DOI: 10.1177/002214650404500104

Source DB:  PubMed          Journal:  J Health Soc Behav        ISSN: 0022-1465


  18 in total

1.  Impact of behavioral genetic evidence on the perceptions and dispositions of child abuse victims.

Authors:  Raymond Raad; Paul S Appelbaum
Journal:  Public Health Genomics       Date:  2014-07-22       Impact factor: 2.000

2.  The Cultural Turn in Sociology: Can It Help Us Resolve an Age-Old Problem in Understanding Decision Making for Health Care?

Authors:  Bernice A Pescosolido; Sigrun Olafsdottir
Journal:  Sociol Forum (Randolph N J)       Date:  2010-12

3.  Attention-deficit/hyperactivity disorder severity, diagnosis, & later academic achievement in a national sample.

Authors:  Jayanti Owens; Heide Jackson
Journal:  Soc Sci Res       Date:  2016-06-25

4.  Unmet need for treatment for substance use disorders across race and ethnicity.

Authors:  Norah Mulvaney-Day; Darcie DeAngelo; Chih-Nan Chen; Benjamin L Cook; Margarita Alegría
Journal:  Drug Alcohol Depend       Date:  2012-06-02       Impact factor: 4.492

5.  Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African American families in an inner city community.

Authors:  Susan dosReis; Arlene Butz; Paul H Lipkin; Julia S Anixt; Courtney L Weiner; Robin Chernoff
Journal:  J Behav Health Serv Res       Date:  2006-10       Impact factor: 1.505

6.  American parents' willingness to prescribe psychoactive drugs to children: a test of cultural mediators.

Authors:  David Cohen; Frank R Dillon; Hugh Gladwin; Mario De La Rosa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-05-29       Impact factor: 4.328

7.  The meaning of attention-deficit/hyperactivity disorder medication and parents' initiation and continuity of treatment for their child.

Authors:  Susan DosReis; Matthew P Mychailyszyn; Sara E Evans-Lacko; Alicia Beltran; Anne W Riley; Mary Anne Myers
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-08       Impact factor: 2.576

Review 8.  Public stigma of mental illness in the United States: a systematic literature review.

Authors:  Angela M Parcesepe; Leopoldo J Cabassa
Journal:  Adm Policy Ment Health       Date:  2013-09

9.  Public knowledge, beliefs, and treatment preferences concerning attention-deficit hyperactivity disorder.

Authors:  Jane D McLeod; Danielle L Fettes; Peter S Jensen; Bernice A Pescosolido; Jack K Martin
Journal:  Psychiatr Serv       Date:  2007-05       Impact factor: 3.084

10.  Measurement of stigmatization towards adults with attention deficit hyperactivity disorder.

Authors:  Anselm B M Fuermaier; Lara Tucha; Janneke Koerts; Anna K Mueller; Klaus W Lange; Oliver Tucha
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.